Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Healthcare Industry News Hunterbrook Capital backs Achieve Life Sciences as FDA decision nears for cytisinicline Hunterbrook Capital discloses a position in Achieve Life Sciences, citing cytisinicline’s potential to disrupt the smoking cessation market ahead of FDA review. bySrinathDecember 31, 2025